US SB3934 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 14 2024 - 25% progression
Action: 2024-03-14 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 14 2024 - 25% progression
Action: 2024-03-14 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
Title
Increasing Access to Biosimilars Act of 2023
Sponsors
| Sen. John Cornyn [R-TX] | Sen. Michael Bennet [D-CO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-14 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB1352 (Related) 2023-12-06 - Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/3934/all-info |
| Text | https://www.congress.gov/118/bills/s3934/BILLS-118s3934is.pdf |
